Robotic physiotherapist could treat patients and cut waiting times

A robotic system to treat physiotherapy patients with lower limb problems could lead to a decrease in waiting lists and the ability for patients to be treated outside of clinics.The prototype NeXOS system can be instructed to remember and repeat specific limb movements which have been programmed by a physiotherapist. This removes the need for the physiotherapist to manipulate the patient's limbs manually, so that they would not need to be present when the exercises were taking place. It i...Monday, 12-Feb-2007 / [ Details... ]

New technologies boost production of malaria drug artemisinin

New technologies that make the large-scale extraction of a natural antimalarial 'wonder drug' both cheaper and greener are to be developed and trialled in a new European effort. Since it was first extracted from the herb Sweet Wormwood (Artemisia annua) by Chinese scientists in the 1980s, artemisinin has proven to be a potent anti-malarial treatment. Most patients treated with Artemisinin-based Combination Treatments (ACTs) show clinical improvement within 24 hours. However, large-...Monday, 12-Feb-2007 / [ Details... ]

FDA approves absorbable polymer suture that uses DNA technology

The U.S. Food and Drug Administration (FDA) has announced it has cleared for marketing in the U.S. the TephaFLEX Absorbable Suture - the first absorbable polymer suture made from material isolated from bacteria modified by recombinant DNA technology. Recombinant DNA technology uses living organisms to create chemicals that may be more difficult to produce under standard industrial methods."The TephaFLEX Absorbable Suture is made from material...Monday, 12-Feb-2007 / [ Details... ]

New microscopy technology

Research is finding evidence that may solve one of the great puzzles of 21st Century medicine using a new microscopy technology known as CytoViva. Researchers at Mayo Clinic successfully isolated nanoparticles from human kidney stones and calcified aortas. The findings, which appear in the Journal of Investigative Medicine, are significant because they move researchers a step closer to understanding whether nanoparticles can contribute to the ...Sunday, 11-Feb-2007 / [ Details... ]

New diagnostic technology for routine prenatal genetic testing

Research studies demonstrating the viability of an approach to routinely detect the presence of fetal DNA in a mother's blood to accurately diagnose or rule out genetic defects -- as early as the first trimester -- was presented today at the 27th Annual Meeting of the Society for Maternal-Fetal Medicine being held in San Francisco. This future diagnostic technology, currently under development at Sequenom, Inc. , shows promise that a universal...Sunday, 11-Feb-2007 / [ Details... ]

New hospital gowns to combat MRSA

The fight against the MRSA bug will take a step forward this week when a new-style hospital gown goes on trial at a London hospital. The patient gown combines a new and innovative design with an anti-microbial finish that controls the growth of bacteria. The gown's unique design aims to reduce the spread of infection by minimising patient handling. It facilitates access to the patient's body for examination and makes it easier to change than regular gowns. Less patient handling means less...Sunday, 11-Feb-2007 / [ Details... ]

Smart technology cuts physiotherapy waiting times

Technology with the potential to help cut physiotherapy waiting times has been unveiled by the University of Abertay Dundee.Researchers in Abertay's School of Computing and Creative Technologies have developed an intelligent exoskeleton that can be programmed to remember and repeat specific limb movements.The NeXOS system will enable physiotherapists to devise exercise programmes customized to the individual needs of any patient with lo...Sunday, 11-Feb-2007 / [ Details... ]

FDA approves temporary limb salvage shunt

The U.S. Food and Drug Administration (FDA) has cleared for U.S. marketing a vascular shunt, a medical device that can help save the arms and legs of soldiers critically injured in combat as well as individuals in other trauma settings and emergency situations. The Temporary Limb Salvage Shunt (TLSS), made by Vascutek Ltd. (Renfrew, Scotland), was reviewed by FDA in less than one week because of the critical need for such a device. "This devi...Sunday, 11-Feb-2007 / [ Details... ]

Machine learning speeds up Intensity Modulated Radiation Therapy

A new computer-based technique could eliminate hours of manual adjustment associated with a popular cancer treatment. In a paper published in the Feb. 7 issue of Physics in Medicine and Biology, researchers from Rensselaer Polytechnic Institute and Memorial Sloan-Kettering Cancer Center describe an approach that has the potential to automa...Wednesday, 7-Feb-2007 / [ Details... ]

FDA clears MammaPrint test for marketing

The Food and Drug Administration (FDA) has cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity.The MammaPrint test uses the latest in molecular technology to predict whether existing cancer will metastasize (spread to other parts of a patient's body). The test relies on microarray analysi...Tuesday, 6-Feb-2007 / [ Details... ]

...Prev  1 2 3 4 5 6 7 8 9 10 11 Next...
Total: 803

© 2006,, All Rights Reserved.